Classification
Product TypeIngredient
Product FormExtract
Industry PositionFood and dietary supplement ingredient
Market
Guarana extract in the United States is primarily an imported botanical stimulant ingredient used by dietary supplement and functional beverage manufacturers. Market access is driven more by FDA regulatory compliance (identity, safety, labeling, and importer verification) than by domestic agricultural production.
Market RoleImport-dependent manufacturing and consumer market (net importer)
Domestic RoleFormulation ingredient for dietary supplements, functional beverages, and sports nutrition products
SeasonalityAvailability is driven by import and inventory cycles rather than U.S. harvest seasonality.
Specification
Physical Attributes- Typically supplied as a dry extract (powder) or liquid extract for industrial formulation
Compositional Metrics- Caffeine content standardization per buyer specification (with supporting Certificate of Analysis)
- Botanical identity confirmation (ingredient authenticity testing) to reduce adulteration risk
- Microbiological and heavy metals testing aligned to buyer and regulatory risk management
Packaging- Bulk packaging suitable for ingredient distribution (buyer-specified to protect against moisture and contamination)
Supply Chain
Value Chain- Overseas extraction/standardization → bulk shipment to U.S. → U.S. customs + FDA entry procedures → ingredient distributor/warehouse → manufacturer formulation (supplement/beverage) → finished-goods retail channels
Temperature- Typically managed as an ambient-stable ingredient; protect from excessive heat and moisture to preserve quality and prevent caking/degradation
Shelf Life- Shelf-life and release-to-use decisions typically rely on lot-specific COA, storage controls (dry, sealed), and buyer quality agreements
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Enforcement HighU.S. regulatory non-compliance (e.g., adulteration concerns, inadequate identity testing, or importer verification/documentation gaps) can trigger FDA/port holds, refusal, or detention, disrupting supply into the U.S. market.Use a U.S.-ready quality dossier per lot (COA + identity testing + contaminant testing as risk-assessed), align labeling/ingredient status assessment for intended use, and maintain importer verification records consistent with FDA expectations.
Documentation Gap MediumMismatch between customs entry data, product description, and quality/identity documents can cause clearance delays and increase inspection probability.Harmonize product naming, HTS classification rationale, and COA/spec sheets across supplier, broker, and importer-of-record documentation before shipment.
Chemical Contaminants MediumHeavy metals or other contaminants in botanical extracts can create downstream compliance and brand risk in U.S. finished products (including heightened scrutiny in certain states and retail programs).Implement risk-based testing (heavy metals and relevant contaminants), define action limits in quality agreements, and verify accredited lab methods for each lot.
Labeling and Claims MediumFinished-product stimulant/energy positioning increases risk of U.S. enforcement or disputes if claims are not appropriately substantiated or if labeling does not align with dietary supplement requirements.Keep claims within compliant categories, document substantiation, and run pre-launch label and claims review with U.S. regulatory counsel.
Standards- FDA dietary supplement cGMP alignment (21 CFR Part 111) expectations in supplier qualification
- Third-party audits/certifications used by U.S. buyers (e.g., ISO 22000 / FSSC 22000) where required by customer programs
FAQ
What are the main U.S. compliance expectations when importing guarana extract for dietary supplement use?U.S. importers typically need supplier qualification and verification records, and manufacturers of finished dietary supplements must follow FDA dietary supplement rules, including cGMP requirements. Shipments may also need FDA prior notice as applicable to imported foods.
What documentation is commonly expected for U.S. buyers of guarana extract?U.S. buyers commonly expect a lot-specific Certificate of Analysis (including identity and key assays such as caffeine) and consistent import documentation that matches the customs product description and classification used for entry.
How can import clearance risk be reduced for guarana extract entering the U.S.?Reduce risk by aligning the product description and HTS classification across broker and importer paperwork, maintaining FDA-facing import documentation where applicable, and keeping complete lot traceability and testing records to support identity and safety.
Sources
U.S. Food and Drug Administration (FDA) — Dietary Supplement Health and Education Act (DSHEA) and dietary supplement regulatory overview
U.S. Food and Drug Administration (FDA) — Current Good Manufacturing Practice (cGMP) regulations for dietary supplements (21 CFR Part 111)
U.S. Food and Drug Administration (FDA) — FSMA Foreign Supplier Verification Programs (FSVP) for importers (21 CFR Part 1, Subpart L)
U.S. Food and Drug Administration (FDA) — Prior Notice of Imported Foods requirements
United States International Trade Commission (USITC) — Harmonized Tariff Schedule of the United States (HTS) reference for classification and duty rates
U.S. Customs and Border Protection (CBP) — Customs entry and import compliance guidance (classification, marking, and entry filing)